CDK2 and ovarian carcinoma: Moreover, the evaluation of the miR-124 overexpression in MSC exosomes has shown the proliferation inhibition of ovarian cancer cells by arrest induction in the S phase through the downregulation of Cyclin-Dependent Kinase 2 (CDK2), CDK4, and CDK6 [73].